CDMO: Avid Bioservices Company Aggregate Debts

Symbol and logo of brand Avid Bioservices Inc. (CDMO)

The market value dynamics of the asset on the GURU.Markets platform show figures at 0.19. Avid Bioservices, Inc. (CDMO) generates revenue from the production of antibodies and biologics, relying on a broad client base ranging from small firms to tech giants. Growth is driven by US protectionism and the West's pursuit of autonomy. High customer loyalty is ensured by rigorous quality control and the complexity of switching certified suppliers.

CDMO: Avid Bioservices, Inc. Company Debts 07/04/2022 - 02/16/2025

Avid Bioservices (CDMO) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart Avid Bioservices Inc|CDMO - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Avid Bioservices, Inc|CDMO - Total Company Value
- balance sheet equity data:
Accounting Value of a Share Avid Bioservices|CDMO - Company Book Value|Market Cap to Net Assets Ratio avidbio.com|CDMO - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Avid Bioservices, Inc.|CDMO - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Avid Bioservices Inc.|CDMO - Company Total Debt|Debt to Book Capital Avid Bioservices, Inc|CDMO - Company Long-Term Debts|Short-Term Debt Avid Bioservices|Interim Coverage Ratio avidbio.com
- earnings and valuation multiples information:
CDMO - Net Income
Summary company analytics:Avid Bioservices Inc
Signature product of Avid Bioservices Inc.

By diversifying its order book through contract manufacturing for numerous pharmaceutical companies, Avid Bioservices, Inc. (CDMO) optimizes operational risks. An analysis of net total debt, combining loan obligations and bonds, allows for an assessment of financial leverage and the speed of resource mobilization for scaling, while the total debt trajectory serves as an indicator of the business's resilience to shifting market cycles.

Competing companies

IQV (Quintiles) - Aggregate Debt Obligations|Company Aggregate Debts LH (Labcorp Holdings Inc.)|Company Aggregate Debts medpace.com MEDP|ICLR - Company Debts|Aggregate Debt Obligations CRL (Charles River Laboratories International, Inc.)|Evotec Corp (EVO) - Company Debts|Company Total Debt Fortrea Clinical|LFCR (Lifecore Biomedical Inc.) - Company Aggregate Debts|Company Aggregate Debts omniab.com|Company Total Debt NOTV (Inotiv)|CTLT (Catalent Inc.) - Aggregate Debt Obligations|NightHawk Biosciences - Company Total Debt